Searched for
RAJESH VISWANATHAN
Who gets what in Vijay’s Tamil Nadu Cabinet as Congress, VCK, IUML join power tableTamil Nadu's political landscape has shifted with Chief Minister C Joseph Vijay forming a 35-member coalition ministry. This new government...- Tamil Nadu CM Vijay expands cabinet by inducting 23 more ministers, Congress joins govtThe newly expanded Cabinet also includes four women ministers. Governor Vishwanath Arlekar administered the oath of office and secrecy to t...
- Tamil Nadu Cabinet Expansion: CM Vijay adds 23 more ministers to TVK-led govt, shuffles some portfoliosT.N. Cabinet Expansion Updates: Tamil Nadu's new government has expanded its cabinet. Twenty-three more MLAs joined the State Cabinet. This...
- Tamil Nadu ministers list 2026: From Maria Wilson to Srinath, here is the full list of Vijay’s cabinetTN ministers list 2026: Tamil Nadu Chief Minister C. Joseph Vijay has expanded his Cabinet by inducting 23 MLAs and assigning portfolios ac...
- Congress to have 2 ministers in Tamil Nadu, to join Tamil Nadu cabinet after 59 yrsThe Congress party is set to join the Tamil Nadu cabinet after a 59-year hiatus. Two Congress MLAs, Rajesh Kumar and P Viswanathan, will be...
- Supreme Court rules no personal hearing needed before declaring bank account as fraudThe Supreme Court has issued a pivotal directive concerning the classification of bank accounts as fraudulent, opting not to allow personal...
- Former NASSCOM VP joins Peoplefy's strategic advisory board"With over 40+ years of experience in the IT/ITES and GCC eco-system, KS Viswanathan brings a wealth of knowledge to Peoplefy's advisory bo...
- Buy Ajanta Pharma, target price Rs 1580: ICICI SecuritiesAjanta Pharma, incorporated in the year 1979, is a Mid Cap company (having a market cap of Rs 18277.05 Crore) operating in Pharmaceuticals ...
- Buy Ajanta Pharma, target Rs 1065: Jayesh BhanushaliBuy Ajanta Pharma Ltd. at a price target of Rs 1065.0 and a stoploss at Rs 988 from entry point.
- Sell Ajanta Pharma, target Rs 1040: Dr CK NarayanSell Ajanta Pharma Ltd. at a price target of Rs 1040.0 and a stoploss at Rs 1065 from entry point.
- Buy Ajanta Pharma, target Rs 1225: Manas JaiswalBuy Ajanta Pharma Ltd. at a price target of Rs 1225.0 and a stoploss at Rs 1140 from entry point.
- Sell Ajanta Pharma, target Rs 1075: Kunal BothraSell Ajanta Pharma Ltd. at a price target of Rs 1075.0 and a stoploss at Rs 1125 from entry point.
- Buy Ajanta Pharma, target Rs 1250: Manas JaiswalBuy Ajanta Pharma Ltd. at a price target of Rs 1250.0 and a stoploss at Rs 1160 from entry point.
- No chance given to explain: AAP MLAs to HC on disqualificationThe MLAs submitted before a bench of Delhi High Court that the poll panel had sent its opinion to President Ram Nath Kovind by "flouting th...
- Buy Ajanta Pharma, target Rs 1275: Dr CK NarayanBuy Ajanta Pharma Ltd. at a price target of Rs 1275.0 and a stop loss at Rs 1245 from entry point.
- Sell Ajanta Pharma, target Rs 1195.0 : Dr CK NarayanSell Ajanta Pharma Ltd. at a price target of Rs 1195.0 and a stop loss at Rs 1225 from entry point.
- Madras High Court stays look out circular against Karti Chidambaram, 4 othersJustice granted interim stay when petitions filed by Karti & others seeking to quash the circulars came up for hearing and directed the cen...
- TCS’ Mr Dependable Ravi Viswanathan is new marketing chiefViswanathan will be based in Chennai, and his earlier role - managing emerging geographies - has been given to HR head Ajoyendra Mukherjee.
- TCS top bench may thin out in post-Chandrasekaran eraAs CFO, Gopinathan does necessarily have the kind of client connect that any of TCS' five geography heads and its industry and service line...
- Bajaj Finance Q3 net profit up 58% at Rs 408 croreDuring the quarter, the company sold NPA receivables of Rs 82 crore in mortgage business on cash basis. This helped improve gross NPA and n...
Load More
